Ebola and Malaria: Why Can Fever Be Hard to Diagnose?

Why can Ebola and malaria cause confusion early in illness?

The concern extends beyond recognizing Ebola. When fear discourages people from seeking help, other infections may also go untreated. Reuters reported that some parents were trying self-medication before bringing children to hospital. That reporting highlights an access problem; it does not establish which infection explains an individual child's fever. [Reuters report, October 14](https://www.internazionale.it/ultime-notizie-reuters/2026/10/14/as-ebola-spreads-in-eastern-congo-mothers-and-children-shun-vital-care).

WHO describes substantial overlap between early Ebola symptoms and illnesses including malaria, typhoid fever and meningitis. Ebola symptoms can develop 2–21 days after infection and may include fever, profound tiredness, muscle aches and headache. Bleeding is less frequent than popular portrayals suggest and may appear later, so its absence cannot exclude the disease. Clinicians need laboratory evidence alongside the patient's symptoms and exposure history. [WHO Ebola fact sheet](https://www.who.int/news-room/fact-sheets/detail/ebola-disease).

How should malaria testing proceed when Ebola is suspected?

CDC guidance explicitly advises hospitals to continue assessment, laboratory testing and appropriate treatment for other likely illnesses during an Ebola evaluation. Teams should assess exposure risk, coordinate with public health specialists and protect staff handling patients or specimens. The practical implication is that investigating Ebola and treating another urgent condition may need to proceed together. Waiting for the outbreak-related question to be resolved can create an avoidable delay. [CDC clinical guidance for Ebola disease](https://www.cdc.gov/ebola/hcp/clinical-guidance/index.html).

Malaria testing looks for evidence of the parasite. Blood-smear microscopy can identify parasites, help determine their species and measure how heavily the blood is infected. Rapid diagnostic tests detect parasite antigens, while molecular tests detect genetic material. Test limitations matter: CDC notes that a negative rapid malaria test does not reliably exclude infection. Further testing depends on the initial method, clinical suspicion and local protocols. These investigations require trained staff and appropriate specimen-handling safeguards when Ebola is also suspected. [CDC malaria evaluation and diagnosis](https://www.cdc.gov/malaria/hcp/clinical-guidance/evaluation-and-diagnosis.html).

Why is prompt fever assessment especially important for children and pregnant patients?

WHO identifies infants, children younger than five and pregnant women among the groups at increased risk of severe malaria. Symptoms typically begin 10–15 days after an infective mosquito bite, although timing varies. Untreated Plasmodium falciparum malaria can progress to severe illness and death within 24 hours. Malaria during pregnancy can also contribute to premature delivery and low birth weight. These risks explain why a fever should not be dismissed simply because attention is focused on another infection. [WHO malaria fact sheet](https://www.who.int/news-room/fact-sheets/detail/malaria).

Difficulty breathing, impaired consciousness or repeated seizures warrant emergency assessment. Families should tell the receiving team promptly about any possible Ebola exposure so appropriate arrangements can be made. For clinicians, immediate priorities include assessing illness severity and providing necessary supportive treatment while investigations proceed. CDC emphasizes that early supportive care improves outcomes in Ebola and that evaluating suspected infection must not interrupt appropriate care for other conditions. [WHO malaria warning signs](https://www.who.int/news-room/fact-sheets/detail/malaria), [CDC Ebola care guidance](https://www.cdc.gov/ebola/hcp/clinical-guidance/index.html).